Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Human resources as determinants of pharmaceutical production efficiency

214
Article(UKR)(.pdf)

The article dwells upon to the human resources of the pharmaceutical production as the determinant of its effectiveness. The author shows that human resources as well as the R&D capacity, should be regarded as one of the high-tech manufacturing key indicators. Based on the reports of the European Federation of Pharmaceutical Industry and Associations (EFPIA) and EUROSTAT the estimation of employment scale in the pharmaceutical countries – EU members was carried out. It is established that the EU pharmaceutical industry employed 725 thousand people, including 118 thousand of those involved in R&D. Paper considers the provision of human resources in the pharmaceutical and activities related to R&D, the rate of which is increasing every year. In order to clarify that EU Member States have the largest concentration of specialists working in the pharmaceutical industry, the employment ratio was calculated with the rate per capita in the country’s pharmaceutical industry and the total population of the country.

According to calculations by the EUROSTAT data, it was found that the highest productivity compared to other high-tech sectors is concentrated in pharmaceuticals. It was revealed that pharmaceutical production is characterized by a high rate of direct and indirect employment.

According to the results, it was discovered that pharmacy is the most effective industry among the high-tech ones. Based on US NSF the author defined the countries with the highest concentration of employment in manufacturing and countries that are the most effective for creating added value. According to the results it was determined that the efficiency of pharmaceutical production in Ukraine is lower, in general, then in the countries – EU members, despite the fact that the implementation of R&D to obtain new drugs or reproduction (imitation) of specialties requires highly qualified personnel, enumeration of which is growing in the domestic pharmaceutical industry with every year, despite the general trend of reducing employment in industrial sector.

This article may be useful for students, teachers, researchers and government officials, who work in the high-tech pharmaceutical sector.

  1. Salikhova, O.B. (2013). Development of human resources and the commercialization of high technologies: international experience and lessons for Ukraine. Vysokotekhnolohichna sfera promyslovosti Ukrainy: resursni mozhlyvosti rozvytku – High-tech industry sector Ukraine: resource development opportunities, 5, 217-272 [in Ukrainian].

  2. Posylkina, O.V., Bratishko, Yu.S, Kubasova, G.V. (2014). Detection of currently important issues of personnel management of industrial pharmaceutical enterprises. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii – Management, economics and quality assurance in pharmacy, 1, 16-22 [in Ukrainian].

  3. Posylkina, A.V. (2002). Innovation and investment development of pharmaceutical production: the problem of financial security. Kharkiv: Izd pharmacy: Golden Pages [in Ukrainian].

  4. Bratishko, Yu.S. (2008). The management of labor potential of industrial pharmaceutical enterprises in the implementation of international quality standards: autoabst. dis. … cand. pharm. sciences. Kharkiv: National University of Pharmacy [in Ukrainian].

  5. Posylkina, A.V., Dorovskykh, O.V., Bratishko, Y.S., Sidorenko, M.I. (2010). Management tabor potential of the pharmaceutical enterprises in terms of management quality. Kharkiv: Pharmacy [in Ukrainian].

  6. Salikhova, O.B. (2012). High-tech production: from assessment methodology to rise in Ukraine: the monograph. Kyiv: Institute for Economics and Forecasting, National Academy of Science of Ukraine [in Ukrainian].

  7. Hecker, D.E. (2005). High-technology employment: a NAICS-based update. Monthly Labor Review, 57-72.

  8. Science and Engineering Indicators 2016. URL: http://www.nsf.gov/

  9. PhRMA (2012) PhRMA releases new data on biopharmaceutical industry’s contributions to local, state economies. Pharmaceutical Research and Manufacturers of America, press release, November 13. URL: http://phrma.org/media/releases/phrma-releases-new-data-biopharmaceutical-industry-contributions-local-state-economies

  10. The Pharmaceutical Industry in figures. URL: http://www.efpia.eu/

  11. Salikhova, O.B. (2007). Identification methods of Ukrainian high-tech production entreprises. In II technology market: problems and solutions: abstracts. Kyiv, 5–6 December, 2007 (pp. 139-145). Kyiv: UkrISTEI [in Ukrainian].

  12. Eurostat statistics explained. URL: http://ec.europa.eu/eurostat/statistics-explained/index.php/Glossary:Apparent_labour_productivity_-_SBS

  13. OECD. Labour productivity indicators. URL: http://www.oecd.org/employment/labour-stats/41354425.pdf

  14. Salikhova, O.B., Duiun, D.O. Ukrainian pharmaceutical manufacturers are on the hook, but on a high-tech one. URL: http://ua-ekonomist.com/12866-ukrayinsk-farmvirobniki-na-gachku-ale-visokotehnologchnomu.html [in Ukrainian].

Full text